Endogenous basal nitric oxide production does not control myocardial oxygen consumption or function

Proceedings of the Society for Experimental Biology and Medicine

Volumn 211, Issue 4, 1996, Pages 332-338

  Sadoff, John D ^a   Scholz, Peter M ^a   Weiss, Harvey R ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL REACTIVITY; DOG; HEART FUNCTION; HEART MUSCLE OXYGEN CONSUMPTION; NONHUMAN; VASODILATATION;

ANIMALIA; CANIS FAMILIARIS;

EID: 0029914217     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-211-43977     Document Type: Article

References (31)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991.
2. Brady AB, Warren JB, Poole-Wilson P, Williams T, Harding SE. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265:H176-H182, 1993.
3. Kelm M, Schrader J. Control of coronary vascular tone by nitric oxide. Circ Res 66:1561-1575, 1990.
4. Murad F, Forstermann V, Nakane M, Schmidt H, Pollock J, Sheng H, Matsumoto T, Warner T, Mitchell J, Tracey R, Buechler W. The nitric oxide-cGMP signal transduction pathway in vascular smooth muscle preparations and other tissues. Jpn J Pharm 58(Suppl 2):150-157, 1992.
5. Amrani M, O'Shea J, Allen NJ, Harding SE, Jayakumar J, Pepper JR, Moncada S, Yacoub MH. Role of basal release of nitric oxide on coronary flow and mechanical performance of the isolated rat heart. J Physiol (Lond) 456:681-687, 1992.
6. Michel T, Smith T. Nitric oxide synthases and cardiovascular signaling. Am J Cardiol 72:33C-38C, 1993.
7. Balligand JL, Kelly RA, Marsden PA, Smith TW, Michel T. Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci USA 90:347-351, 1993.
8. Weyrich AS, Ma X-L, Buerke M, Murohara T, Armstead VE, Fefer AM, Nicolas JM, Thomas AP, Lefer DJ, Vinten-Johansen J. Physiological concentrations of nitric oxide do not elicit an acute negative inotropic effect in unstimulated cardiac muscle. Circ Res 75:692-700, 1994.
9. Fort S, Lewis MJ, Shah AM. The role of endocardial endothelium in the modulation of myocardial contraction in the isolated whole heart. Cardioscience 4:217-223, 1993.
10. Shah AM, Lewis MJ. Endothelial modulation of myocardial contraction: Mechanisms and potential relevance in cardiac disease. Basic Res Cardiol 87(Suppl 2):59-70, 1992.
11. Weiss HR, Rodriguez E, Tse J, Scholz PM. Effect of increased myocardial cyclic GMP induced by cyclic GMP-phosphodiesterase inhibition on oxygen consumption and supply of rabbit hearts. Clin Exp Pharmacol Physiol 21:607-614, 1994.
12. Paulus WJ, Vantrimpont PJ, Shah AM. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans: Assessment by bicoronary sodium nitroprusside infusion. Circulation 89:2070-2078, 1994.
13. de Beider AJ, Radomski MW, Why HJF, Richardson PJ, Bucknail CA, Salas E, Martin JF, Moncada S. Nitric oxide synthase activities in human myocardium. Lancet 341:84-85, 1993.
14. Lohmann SM, Fischmeister R, Walter U. Signal transduction by cGMP in heart. Bas Res Cardiol 86:503-514, 1991.
15. Roitstein A, Kedem J, Cheinberg B, Weiss HR, Tse J, Scholz PM. The effect of intracoronary nitroprusside on cyclic GMP and regional mechanics is altered in a canine model of left ventricular hypertrophy. J Surg Res 57:584-590, 1994.
16. Guo X, Kedem J, Roitstein A, Tse J, Scholz PM, Weiss HR. Effect of intracoronary methylene blue on regional myocardial mechanics and cyclic GMP in experimental left ventricular hypertrophy (LVH). FASEB J 8:A310, 1994.
17. Mubagwa K, Shirayama T, Moreau M, Pappano AJ. Effects of PDE inhibitors and carbachol on the L-type Ca current in guinea pig ventricular myocytes. Am J Physiol 265:H1353-H1363, 1993.
18. Kirkeboen KA, Naess PA, Offstad J, Ilebekk A. Effects of regional inhibition of nitric oxide synthesis in intact porcine hearts. Am J Physiol 266:H1516-H1527, 1994.
19. Gurevicius J, Salem MR, Metwally AA, Silver JM, Crystal GJ. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis. Am J Physiol 268:H39-H47, 1995.
20. Parent R, al-Obaidi M, Lavallee M. Nitric oxide formation contributes to beta-adrenergic dilation of resistance coronary vessels in conscious dogs. Circ Res 73:241-251, 1993.
21. Smith TP Jr., Canty JM Jr. Modulation of coronary autoregulatory responses by nitric oxide: Evidence for flow-dependent resistance adjustments in conscious dogs. Circ Res 73:232-240, 1993.
22. G-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res 72:387-395, 1993.
23. Kedem J, Lee WW, Weiss HR. An experimental technique for estimating regional myocardial segment work in vivo. Ann Biomed Eng 22:58-65, 1994.
24. Tremblay J, Gerzer R, Hamet P. Cyclic GMP in cell function. Adv Second Messenger Phosphoprot Res 22:319-383, 1988.
25. Marczin N, Ryan US, Catravas JD. Methylene blue inhibits nitrovasodilator and endothelium-derived relaxing factor-induced cyclic GMP accumulation in cultured pulmonary arterial smooth muscle cells via generation of superoxide anion. J Pharmacol Exp Ther 263:170-179, 1992.
26. Merkel LA, Rivera LM, Perjone MH, Lappe RW. In vitro and in vivo interactions of nitrovasodilators and zaprinast, a cGMP-selective phosphodiesterase inhibitor. Eur J Pharmacol 216:29-35, 1992.
27. Watanabe AM, Besch HR Jr. Interaction between cyclic adenosine monophosphate and cyclic guanosine monophosphate in guinea pig ventricular myocardium. Circ Res 37:309-316, 1975.
28. 2+ current in guinea pig ventricular cells. J Physiol (Lond) 443:387-404, 1991.
29. Shindo T, Ikeda U, Ohkawa F, Takahashi M, Funayama H, Nishinaga M, Kawahara Y, Yokoyama M, Kasahara T, Shimada K. Nitric oxide synthesis in rat cardiac myocytes and fibroblasts. Life Sci 55:1101-1108, 1994.
30. Grocott-Mason R, Anning P, Evans H, Lewis MJ, Shah AM. Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol 267: H1804-H1813, 1994.
31. Hare JM, Keaney JF Jr., Balligand JL, Loscalzo J, Smith TW, Colucci WS. Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs. J Clin Invest 95:360-366, 1995.